David Y. Mason

9.0k total citations
103 papers, 6.2k citations indexed

About

David Y. Mason is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, David Y. Mason has authored 103 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pathology and Forensic Medicine, 34 papers in Genetics and 30 papers in Oncology. Recurrent topics in David Y. Mason's work include Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (34 papers) and Viral-associated cancers and disorders (19 papers). David Y. Mason is often cited by papers focused on Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (34 papers) and Viral-associated cancers and disorders (19 papers). David Y. Mason collaborates with scholars based in United Kingdom, France and Germany. David Y. Mason's co-authors include Georges Delsol, Karen Pulford, Laurence Lamant, Karen Pulford, Stephan W. Morris, Kevin C. Gatter, Brunangelo Falini, Stefano Pileri, S. W. Morris and Daniela Bischof and has published in prestigious journals such as The Lancet, Blood and Molecular and Cellular Biology.

In The Last Decade

David Y. Mason

103 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Y. Mason United Kingdom 40 4.0k 2.4k 1.5k 1.5k 1.3k 103 6.2k
Jan Delabie Norway 48 4.7k 1.2× 3.2k 1.3× 1.7k 1.2× 1.4k 0.9× 1.9k 1.4× 201 7.0k
Philip M. Kluin Netherlands 47 3.1k 0.8× 2.3k 1.0× 1.6k 1.1× 1.3k 0.9× 1.5k 1.1× 130 6.8k
ML Cleary United States 27 5.0k 1.2× 3.1k 1.3× 1.4k 0.9× 1.2k 0.8× 2.1k 1.6× 49 7.5k
Laurence Lamant France 45 4.4k 1.1× 3.3k 1.4× 1.5k 1.0× 1.9k 1.3× 1.1k 0.8× 203 7.9k
Karen Pulford United Kingdom 27 2.5k 0.6× 1.5k 0.6× 825 0.6× 1.2k 0.9× 700 0.5× 49 4.2k
Michelle A. Fanale United States 36 4.1k 1.0× 3.9k 1.6× 1.4k 0.9× 843 0.6× 1.2k 0.9× 252 6.4k
Iwona Włodarska Belgium 52 4.3k 1.1× 3.2k 1.3× 1.7k 1.2× 2.2k 1.5× 2.4k 1.8× 193 8.6k
Thomas Rüdiger Germany 37 3.3k 0.8× 2.6k 1.1× 1.2k 0.8× 723 0.5× 903 0.7× 93 5.0k
Douglas E. Horsman Canada 40 3.2k 0.8× 2.6k 1.1× 891 0.6× 1.7k 1.2× 1.8k 1.3× 115 6.4k
Manuela Mollejo Spain 45 3.1k 0.8× 1.7k 0.7× 1.2k 0.8× 1.2k 0.8× 2.2k 1.6× 133 5.3k

Countries citing papers authored by David Y. Mason

Since Specialization
Citations

This map shows the geographic impact of David Y. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Y. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Y. Mason more than expected).

Fields of papers citing papers by David Y. Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Y. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Y. Mason. The network helps show where David Y. Mason may publish in the future.

Co-authorship network of co-authors of David Y. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of David Y. Mason. A scholar is included among the top collaborators of David Y. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Y. Mason. David Y. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ying, Jianming, Zifen Gao, Hongyu Li, et al.. (2007). Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. British Journal of Haematology. 136(6). 829–832. 44 indexed citations
2.
García, J. F., Giovanna Roncador, Lorena Maestre, et al.. (2006). PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.. PubMed. 91(4). 467–74. 66 indexed citations
3.
Marafioti, Teresa, Cristina Mancini, Stefano Ascani, et al.. (2004). Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.. PubMed. 89(8). 957–64. 21 indexed citations
4.
Haralambieva, Eugenia, Alison H. Banham, Christian Bastard, et al.. (2003). Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin‐embedded lymphoma biopsy samples. British Journal of Haematology. 121(1). 49–56. 35 indexed citations
5.
Marafioti, Teresa, Stefano Ascani, Karen Pulford, et al.. (2003). Expression of B-Lymphocyte-Associated Transcription Factors in Human T-Cell Neoplasms. American Journal Of Pathology. 162(3). 861–871. 34 indexed citations
6.
Hernández, Luís, Sı́lvia Beà, Beatríz Bellosillo, et al.. (2002). Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas. American Journal Of Pathology. 160(4). 1487–1494. 76 indexed citations
7.
Pulford, Karen, et al.. (2002). Immunochemical studies of antigenic 
lymphoma‐associated proteins. British Journal of Haematology. 116(1). 135–141. 6 indexed citations
8.
Haralambieva, Eugenia, Karen Pulford, Laurence Lamant, et al.. (2000). Anaplastic large‐cell lymphomas of B‐cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B‐cell lymphomas. British Journal of Haematology. 109(3). 584–591. 62 indexed citations
9.
Pulford, Karen, Brunangelo Falini, Andreas Rosenwald, et al.. (1999). Biochemical Detection of Novel Anaplastic Lymphoma Kinase Proteins in Tissue Sections of Anaplastic Large Cell Lymphoma. American Journal Of Pathology. 154(6). 1657–1663. 52 indexed citations
10.
Pulford, Karen, Georges Delsol, Giovanna Roncador, et al.. (1999). Immunohistochemical screening for oncogenic tyrosine kinase activation. The Journal of Pathology. 187(5). 588–593. 1 indexed citations
11.
Vergier, B., M. Beylot‐Barry, Karen Pulford, et al.. (1998). Statistical Evaluation of Diagnostic and Prognostic Features of CD30+ Cutaneous Lymphoproliferative Disorders. The American Journal of Surgical Pathology. 22(10). 1192–1202. 68 indexed citations
12.
Kuefer, Martin U., A. Thomas Look, Karen Pulford, et al.. (1997). Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice. Blood. 90(8). 2901–2910. 215 indexed citations
13.
Chan, John K.C., Peter M. Banks, M. L. Cleary, et al.. (1994). A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology. 25(6). 517–536. 62 indexed citations
14.
Pezzella, Francesco, Helen Morrison, Margaret T. Jones, et al.. (1993). Immunohistochemical detection of p53 and bcl‐2 proteins in non‐Hodgkin's lymphoma. Histopathology. 22(1). 39–44. 89 indexed citations
15.
Thomas, J, et al.. (1991). Immunophenotyping of Nigerian cases of non‐Hodgkin's lymphomas on paraffin sections. Histopathology. 18(6). 505–510. 7 indexed citations
16.
Cibull, M L, H. Stein, Kevin C. Gatter, & David Y. Mason. (1989). The expression of the CD3 antigen in Hodgkin's disease. Histopathology. 15(6). 597–605. 35 indexed citations
17.
Robinson, Mary, et al.. (1988). The analysis of malignant tumours of uncertain origin with immunohistological techniques: Clinical follow-up. Clinical Radiology. 39(4). 432–434. 3 indexed citations
18.
Erber, Wendy N., et al.. (1986). APAAP LABELLING OF BLOOD AND BONE-MARROW SAMPLES FOR PHENOTYPING LEUKAEMIA. The Lancet. 327(8484). 761–765. 74 indexed citations
19.
Ralfkiær, Elisabeth, K Hou-Jensen, David Y. Mason, et al.. (1985). Benign and Malignant Lymphocytic Skin Infiltrates Immunological Patterns Recognized by Immunohistochemical Staining with Monoclonal Antibodies. PubMed. 186. 1033–1041. 2 indexed citations
20.
Isaacson, P G, et al.. (1983). Middle Eastern intestinal lymphoma: a morphological and immunohistochemical study.. Journal of Clinical Pathology. 36(5). 489–498. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Delabie Breakdown of academic impact, for papers by Philip M. Kluin Breakdown of academic impact, for papers by ML Cleary Breakdown of academic impact, for papers by Laurence Lamant Breakdown of academic impact, for papers by Karen Pulford Breakdown of academic impact, for papers by Michelle A. Fanale Breakdown of academic impact, for papers by Iwona Włodarska Breakdown of academic impact, for papers by Thomas Rüdiger Breakdown of academic impact, for papers by Douglas E. Horsman Breakdown of academic impact, for papers by Manuela Mollejo
Rankless by CCL
2026